Nonlinear Dynamics to Distribute GeneBio’s Phenyx Worldwide
Geneva, Switzerland, and Newcastle, UK – June 2, 2008 - Geneva
Bioinformatics (GeneBio) SA and Nonlinear Dynamics today announced a
worldwide distribution agreement for GeneBio’s Phenyx and Nonlinear’s
Progenesis LC-MS software, whereby Nonlinear will distribute GeneBio’s
Phenyx MS identification platform. This partnership exploits the
complementary technology of Phenyx and the novel Progenesis LC-MS software
for label-free quantitative analysis.
Under the terms of the agreement, Nonlinear will distribute Phenyx both as a
standalone software package and alongside the Progenesis LC-MS software. The
synergy between the two products, Phenyx for MS-MS identification and
Progenesis LC-MS for quantitative analysis, offers customers a unique and
comprehensive solution building on the extensive reputations of the two
companies in the field of proteomics.
Developed in collaboration with the Swiss Institute of Bioinformatics (SIB),
Phenyx is GeneBio’s renowned software platform for the identification and
characterization of proteins and peptides from mass spectrometry data,
specifically designed to meet the concurrent demands of high-throughput MS
data analysis and dynamic results assessment while offering a flexible user
experience and an adaptable architecture to help instil confidence in
results assessment. (http://phenyx.vital-it.ch/pwi)
Based on the ground breaking technological approach pioneered by the
Progenesis SameSpots software for 2D gel image analysis, Progenesis LC-MS is
a highly innovative research solution for quantitative analysis of
label-free LC-MS data. It applies simple workflows to complex data-sets so
that the researcher can quickly generate reliable conclusions from their
research and gain confidence in their results.
Will Dracup, CEO of Nonlinear Dynamics said, “We are delighted to enter into
this agreement with GeneBio as the Phenyx MS protein characterization
software provides the final link in the quantitative LC-MS analysis workflow
we have developed. Our novel approach to LC-MS analysis uses sophisticated
and intelligent algorithms to rapidly analyse the LC-MS data and accurately
highlight the significantly changing peptides which require further
investigation by MS-MS. Nonlinear are highly enthusiastic about this
partnership with GeneBio who are well respected in this area of MS research
The option to add the Phenyx software platform to this analysis approach
gives our customers a robust, flexible and integrated solution to their MS
identification requirements.”
“This is a major step forward for Phenyx and GeneBio; we are very motivated
about what this distribution deal will bring,” said Nasri Nahas, CEO of
GeneBio. “Our two companies have known and respected each other for quite
some time. Nonlinear’s reputation in the bioinformatics field, their
extended clientele and distribution network are all first-class; this deal
allows us to bring Phenyx even closer to the MS community, especially when
bundled with an innovative tool like Progenesis LC-MS. We look forward to
the great upsides this new collaboration will bring to both parties and to
the successful expansion of our Phenyx business.”
For more information concerning this distribution deal and for Phenyx and
Progenesis LC-MS product demonstrations, please visit the GeneBio and
Nonlinear booths, respectively numbers 27 and 73, at the upcoming ASMS
Conference on Mass Spectrometry in Denver, Colorado, from June 1-5.
About GeneBio
Geneva Bioinformatics (GeneBio) SA is a leading bioinformatics company
providing the life science community with world-class proteomics software
that bridges the gap between information gathering and knowledge generation.
Established in 1997, GeneBio focuses its expertise on protein identification
and characterization as well as proteome imaging, offering clients and
partners a high degree of specialization essential to proteomics research.
Close ties to academic peers and a thorough network of distribution and
strategic partners give the company both unfettered access to scientific
excellence and recognized market presence so that we may best serve the
scientific community. For more information about GeneBio, please visit:
www.genebio.com.
About Nonlinear Dynamics
Nonlinear strive to solve the challenges in the fields of Proteomics and
Biomarker Discovery. This comes from a core strength in developing
innovative, high quality data analysis solutions. The product range includes
analysis software for 1D and 2D electrophoresis gels, Mass Spectrometry (MS)
and LC-MS as well as tools for multivariate statistical analysis. The
revolutionary SameSpots technology is unique to Nonlinear. It transforms the
ability of what can be achieved with proteomics - providing faster accurate
quantitation, enabling cross-lab reproducibility and making robust reliable
statistical analysis available to everyone. Nonlinear sells and supports its
products through its UK headquarters and its USA office, as well as a global
network of partners and OEM resellers.